Et godt til moderat European League Against Rheumatism (EULAR) respons blev opnået af signifikant flere patienter behandlet med rituximab sammenlignet med patienter behandlet med methotrexat alene (tabel 8).
A good to moderate European League Against Rheumatism (EULAR) response was achieved by significantly more rituximab treated patients compared to patients treated with methotrexate alone (Table 9).